glp 1 anesthesia guidelines 2025 Emerging Frontiers in GLP-1 Therapeutics: A Comprehensive Evidence Base ( 2025) glp-1 anesthesia guidelines 2025 Not

J Clin Invest 2024;134:e178239.ArticlePubMedPMC 113

The reduction in body weight achieved through GLP-1RA therapy holds significant implications beyond metabolic health

Obesity rates have almost tripled since 1975, which researchers say is due to a combination of factors, including: Increased access to energy-dense food coupled with reduced physical activity Sleep deprivation Circadian desynchronization Chronic stress A rise in the use of certain medications known to result in weight gain, including some anti-epileptic and psychotropic drugs Other genetic and environmental factors As a result, prescription drug companies have sought their own way to target the treatment of obesity

Curr Opin Endocrinol Diabetes Obes (2013) 20(2):8797